Acute intermittent porphyria: analgesia can be dangerous.
Carlos Dias SilvaJosé Eduardo MateusCarolina TelesTeresa VaioPublished in: BMJ case reports (2019)
Acute intermittent porphyria (AIP) is a rare condition, a metabolic disorder of the haem biosynthesis. An acute crisis of AIP can present as a combination of symptoms, such as abdominal pain, autonomic dysfunction, hyponatremia, muscle weakness and neurological symptoms in the absence of others obvious causes. We report the case of a 53-year-old woman, who was previously diagnosed with AIP 5 weeks after therapeutic suspension has developed an acute disease exacerbation. During hospitalisation, further exacerbation has occurred after analgesia with metamizole. Glucose and hemin infusions resulted in slow improvement. Physical rehabilitation was crucial to peripheral polyneuropathy recovery. Taking into account the porphyrinogenic effect described for metamizole, this drug might have triggered the second attack. Clinical history was sufficient to suspect the diagnosis and to start the treatment immediately, preventing important sequelae.
Keyphrases
- liver failure
- respiratory failure
- drug induced
- chronic obstructive pulmonary disease
- aortic dissection
- abdominal pain
- pain management
- public health
- hepatitis b virus
- oxidative stress
- high intensity
- ultrasound guided
- intensive care unit
- physical activity
- adipose tissue
- skeletal muscle
- emergency department
- blood pressure
- blood glucose
- heart failure
- sleep quality
- blood brain barrier
- mechanical ventilation
- gestational age